ASX:COH - Cochlear Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
A$170.53 -1.36 (-0.79 %)
(As of 12/14/2018 09:11 AM ET)
Previous CloseA$171.89
Today's RangeA$169.09 - A$171.52
52-Week RangeA$129.18 - A$192.80
Volume112,092 shs
Average Volume194,422 shs
Market CapitalizationN/A
P/E Ratio39.96
Dividend Yield1.72%
BetaN/A
Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers cochlear implants, including Nucleus 7 and Kanso sound processors; Carina middle-ear implants and accessories; and Baha bone conduction implants, such as Baha attract system, Baha connect system, Baha softband, Baha 5 sound processor, Baha 5 power, Baha 5 superpower, other sound processors, and wireless accessories. It also provides Cochlear true wireless devices comprising mini microphones, phone clips, and TV streamers; and Cochlear Vistafix bone-anchored facial prosthetic solutions to enhance the attachment and cosmetic outcome of facial prostheses. The company has strategic collaborations with Sensorion and GN Hearing A/S to focus on improving hearing outcomes in patients with cochlear implants. Cochlear Limited was incorporated in 1983 and is headquartered in Sydney, Australia.

Receive COH News and Ratings via Email

Sign-up to receive the latest news and ratings for COH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange ASX
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
Current SymbolASX:COH
Previous Symbol
CUSIPN/A
Phone+61-2-94286555

Debt

Debt-to-Equity Ratio24.18
Current Ratio2.03
Quick Ratio1.35

Price-To-Earnings

Trailing P/E Ratio39.96
Forward P/E Ratio34.24
P/E GrowthN/A

Sales & Book Value

Annual Sales$1.36 billion
Price / SalesN/A
Cash FlowA$1.06 per share
Price / Cash Flow160.80
Book ValueA$10.61 per share
Price / Book16.07

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees3,500
Outstanding SharesN/A
Market Cap$0.00
OptionableOptionable

Cochlear (ASX:COH) Frequently Asked Questions

What is Cochlear's stock symbol?

Cochlear trades on the ASX under the ticker symbol "COH."

Has Cochlear been receiving favorable news coverage?

Press coverage about COH stock has been trending somewhat positive recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Cochlear earned a news impact score of 1.4 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 1.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near term.

Who are some of Cochlear's key competitors?

Who are Cochlear's key executives?

Cochlear's management team includes the folowing people:
  • Mr. Diggory William Howitt, CEO, MD, Pres & Exec. Director (Age 51)
  • Mr. Brent Andrew Cubis, Chief Financial Officer
  • Mr. Jan Janssen, Chief Technology Officer
  • Mr. Richard Brook, Pres of EMEA & Latin American Region
  • Mr. Anthony Manna, Pres of Americas Region

What is Cochlear's stock price today?

One share of COH stock can currently be purchased for approximately A$170.53.

What is Cochlear's official website?

The official website for Cochlear is http://www.cochlear.com/wps/wcm/connect/au/home.

How can I contact Cochlear?

Cochlear's mailing address is 1 University Avenue Macquarie University, SYDNEY, NSW 2109, Australia. The company can be reached via phone at +61-2-94286555.


MarketBeat Community Rating for Cochlear (ASX COH)

Community Ranking:  1.7 out of 5 (star)
Outperform Votes:  98 (Vote Outperform)
Underperform Votes:  198 (Vote Underperform)
Total Votes:  296
MarketBeat's community ratings are surveys of what our community members think about Cochlear and other stocks. Vote "Outperform" if you believe COH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe COH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/14/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel